Integra Lifesciences released its Q2 2024 results this week.
Organic growth reconciliation figures show that Wound Reconstruction and Care sales within the Tissue Technologies division fell from US$ 192.1 m for Q2 YTD 2024 to US$ 168.6 m in Q2 YTD 2024.
https://investor.integralife.com/events-and-presentations
PNV - Banter and General Comments, page-12184
-
- There are more pages in this discussion • 144 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.33 |
Change
0.030(1.30%) |
Mkt cap ! $1.609B | |||
| Open | High | Low | Value | Volume |
| $2.29 | $2.34 | $2.27 | $2.949M | 1.276M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 19139 | $2.31 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.34 | 14111 | 3 |
View Market Depth
| Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
| PNV (ASX) Chart |